197 related articles for article (PubMed ID: 34831221)
41. Role of fibroblast growth factor type 1 and 2 in carbon tetrachloride-induced hepatic injury and fibrogenesis.
Yu C; Wang F; Jin C; Huang X; Miller DL; Basilico C; McKeehan WL
Am J Pathol; 2003 Oct; 163(4):1653-62. PubMed ID: 14507672
[TBL] [Abstract][Full Text] [Related]
42. miR-34b/c regulates doxorubicin-induced myocardial cell injury through ITCH.
Zhang WC; Yang JH; Liu GH; Yang F; Gong JL; Jia MG; Zhang MJ; Zhao LS
Cell Cycle; 2019 Dec; 18(23):3263-3274. PubMed ID: 31627713
[No Abstract] [Full Text] [Related]
43. Glucose tolerance in obese men is associated with dysregulation of some angiogenesis-related gene expressions in subcutaneous adipose tissue.
Minchenko OH; Bashta YM; Minchenko DO; Ratushna OO
Fiziol Zh (1994); 2016; 62(2):12-23. PubMed ID: 29537219
[TBL] [Abstract][Full Text] [Related]
44. Down-regulation of miR-361-5p promotes the viability, migration and tube formation of endothelial progenitor cells via targeting FGF1.
Yang X; Song Y; Sun Y; Wang M; Xiang Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32985665
[TBL] [Abstract][Full Text] [Related]
45. Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy.
Lódi M; Priksz D; Fülöp GÁ; Bódi B; Gyöngyösi A; Nagy L; Kovács Á; Kertész AB; Kocsis J; Édes I; Csanádi Z; Czuriga I; Kisvárday Z; Juhász B; Lekli I; Bai P; Tóth A; Papp Z; Czuriga D
J Transl Med; 2019 Jul; 17(1):229. PubMed ID: 31324258
[TBL] [Abstract][Full Text] [Related]
46. Bone-derived Nestin-positive mesenchymal stem cells improve cardiac function via recruiting cardiac endothelial cells after myocardial infarction.
Lu D; Liao Y; Zhu SH; Chen QC; Xie DM; Liao JJ; Feng X; Jiang MH; He W
Stem Cell Res Ther; 2019 Apr; 10(1):127. PubMed ID: 31029167
[TBL] [Abstract][Full Text] [Related]
47. Increased expression of FGF1-mediated signaling molecules in adipose tissue of obese mice.
Choi Y; Jang S; Choi MS; Ryoo ZY; Park T
J Physiol Biochem; 2016 Jun; 72(2):157-67. PubMed ID: 26847131
[TBL] [Abstract][Full Text] [Related]
48. Elimination or neutralization of endogenous high-molecular-weight FGF2 mitigates doxorubicin-induced cardiotoxicity.
Koleini N; Santiago JJ; Nickel BE; Sequiera GL; Wang J; Fandrich RR; Jassal DS; Dhingra S; Kirshenbaum LA; Cattini PA; Kardami E
Am J Physiol Heart Circ Physiol; 2019 Feb; 316(2):H279-H288. PubMed ID: 30412444
[TBL] [Abstract][Full Text] [Related]
49. Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma.
Doucette TA; Kong LY; Yang Y; Ferguson SD; Yang J; Wei J; Qiao W; Fuller GN; Bhat KP; Aldape K; Priebe W; Bögler O; Heimberger AB; Rao G
Neuro Oncol; 2012 Sep; 14(9):1136-45. PubMed ID: 22753228
[TBL] [Abstract][Full Text] [Related]
50. Cardiac expression of human type 2 iodothyronine deiodinase increases glucose metabolism and protects against doxorubicin-induced cardiac dysfunction in male mice.
Hong EG; Kim BW; Jung DY; Kim JH; Yu T; Seixas Da Silva W; Friedline RH; Bianco SD; Seslar SP; Wakimoto H; Berul CI; Russell KS; Lee KW; Larsen PR; Bianco AC; Kim JK
Endocrinology; 2013 Oct; 154(10):3937-46. PubMed ID: 23861374
[TBL] [Abstract][Full Text] [Related]
51. CHIR99021 and fibroblast growth factor 1 enhance the regenerative potency of human cardiac muscle patch after myocardial infarction in mice.
Fan C; Tang Y; Zhao M; Lou X; Pretorius D; Menasche P; Zhu W; Zhang J
J Mol Cell Cardiol; 2020 Apr; 141():1-10. PubMed ID: 32169551
[TBL] [Abstract][Full Text] [Related]
52. Congenital absence of nitric oxide synthase 3 potentiates cardiac dysfunction and reduces survival in doxorubicin- and trastuzumab-mediated cardiomyopathy.
Zeglinski M; Premecz S; Lerner J; Wtorek P; Dasilva M; Hasanally D; Chaudhary R; Sharma A; Thliveris J; Ravandi A; Singal PK; Jassal DS
Can J Cardiol; 2014 Mar; 30(3):359-67. PubMed ID: 24484915
[TBL] [Abstract][Full Text] [Related]
53. Controlled delivery of fibroblast growth factor-1 and neuregulin-1 from biodegradable microparticles promotes cardiac repair in a rat myocardial infarction model through activation of endogenous regeneration.
Formiga FR; Pelacho B; Garbayo E; Imbuluzqueta I; Díaz-Herráez P; Abizanda G; Gavira JJ; Simón-Yarza T; Albiasu E; Tamayo E; Prósper F; Blanco-Prieto MJ
J Control Release; 2014 Jan; 173():132-9. PubMed ID: 24200746
[TBL] [Abstract][Full Text] [Related]
54. Doxorubicin triggers splenic contraction and irreversible dysregulation of COX and LOX that alters the inflammation-resolution program in the myocardium.
Jadapalli JK; Wright GW; Kain V; Sherwani MA; Sonkar R; Yusuf N; Halade GV
Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1091-H1100. PubMed ID: 30074834
[TBL] [Abstract][Full Text] [Related]
55. Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction.
Hu CH; Wu GF; Wang XQ; Yang YH; Du ZM; He XH; Xiang P
Chin Med J (Engl); 2006 Sep; 119(18):1499-506. PubMed ID: 16996002
[TBL] [Abstract][Full Text] [Related]
56. A Switch from Cell-Associated to Soluble PDGF-B Protects against Atherosclerosis, despite Driving Extramedullary Hematopoiesis.
Tillie RJHA; Theelen TL; van Kuijk K; Temmerman L; de Bruijn J; Gijbels M; Betsholtz C; Biessen EAL; Sluimer JC
Cells; 2021 Jul; 10(7):. PubMed ID: 34359916
[TBL] [Abstract][Full Text] [Related]
57. TUG1 knockdown ameliorates atherosclerosis via up-regulating the expression of miR-133a target gene FGF1.
Zhang L; Cheng H; Yue Y; Li S; Zhang D; He R
Cardiovasc Pathol; 2018; 33():6-15. PubMed ID: 29268138
[TBL] [Abstract][Full Text] [Related]
58. FGF12 restrains mitochondria-dependent ferroptosis in doxorubicin-induced cardiomyocytes through the activation of FGFR1/AMPK/NRF2 signaling.
Tian G; Li J; Wang W; Zhou L
Drug Dev Res; 2024 Feb; 85(1):e22149. PubMed ID: 38349269
[TBL] [Abstract][Full Text] [Related]
59. C1qTNF-related protein 1 attenuates doxorubicin-induced cardiac injury via activation of AKT.
Chen H; Gao L; Huang Z; Liu Y; Guo S; Xing J; Meng Z; Liang C; Li Y; Yao R; Li L; Zhang Y; Gu H; Liu Y
Life Sci; 2018 Aug; 207():492-498. PubMed ID: 29964055
[TBL] [Abstract][Full Text] [Related]
60. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
